# Girisha Fernando

> Girisha Fernando is the CEO and co-founder of Lyfegen, a Basel- and Boston-based healthtech company building software that helps payers, hospitals, pharma companies and medical device makers manage value-based drug pricing, access and rebate agreements. After nearly a decade at Roche in market access, pricing and IT, he left in 2018 to build technology that ties the price of medicine to how well it actually works for patients. He splits his time between Switzerland and New York as Lyfegen pushes into the US market.

- **Role:** CEO & Founder at Lyfegen
- **Organizations:** Lyfegen, Roche (former), Syngenta (former intern)
- **From:** Sri Lanka
- **Nationality:** Swiss (Sri Lankan origin)
- **Known for:** Co-founded and leads Lyfegen, a global value-based drug pricing, access and rebate management platform, Secured partnerships with major pharmaceutical companies and payers including Johnson & Johnson, Pfizer and Sympany, Rose to become one of the youngest directors in his IT department at Roche before age 29

## Career timeline

- **pre-2018** — Interned at Syngenta and took a student job at Roche in Basel
- **2009-2018** — Spent nearly a decade at Roche across commercial, market access, pricing, IT and clinical trial operations, becoming one of the youngest directors in his IT department
- **2018** — Co-founded Lyfegen in Basel with Nico Mros and Michel Mohler to bring technology to value-based drug pricing
- **2020** — Lyfegen secured around $2 million in seed funding
- **2021** — Announced collaborations with major payers and manufacturers including Johnson & Johnson, Pfizer and Sympany
- **2022** — Raised an $8 million Series A, bringing total funding to roughly $11 million
- **2023** — Launched the Model & Agreement Library and grew the team past 30 people; expanded US presence
- **2024** — Latest funding round (Series A extension) reported at about $5.68M in December 2024; total funding around $22.37M

## Achievements

- Co-founded and leads Lyfegen, a global value-based drug pricing, access and rebate management platform
- Secured partnerships with major pharmaceutical companies and payers including Johnson & Johnson, Pfizer and Sympany
- Rose to become one of the youngest directors in his IT department at Roche before age 29
- Raised over $22 million in total funding for Lyfegen across seed and Series A rounds
- Built the Lyfegen Model & Agreement Library, a repository of real value-based drug pricing agreements
- Recognized thought leader and writer on value-based healthcare (MedCity News, Unite.AI)

## Latest updates

- **2024-12** — Lyfegen reported a further funding round of approximately $5.68 million, bringing total funding to roughly $22.37 million.
- **2023-02** — Featured in SWI swissinfo as the founder of a Swiss start-up 'upending how the world pays for medicine,' outlining US expansion and profitability goals.

## Links

- Website: https://lyfegen.com
- LinkedIn: https://www.linkedin.com/in/girishafernando/
- Twitter/X: https://twitter.com/girifernando
- Facebook: https://facebook.com/lyfegen

---

Profile page: https://yespress.io/girisha-fernando
Published by YesPress — https://yespress.io
Last updated: 2026-07-17